![Fredrik Dahl](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fredrik Dahl
Director/Board Member at
DEVYSER DIAGNOSTICS AB
Net worth: 444 692 $ as of 31/05/2026
Profile
Fredrik Dahl is the founder of Colibri Ventures AB,Pixelgen Technologies AB. Currently, Dr. Dahl is Chairman at Faboss Invest AB, Director at Devyser Diagnostics AB starting 2025, Director at Nucleus Capital AB, and Director at Llya Pharma AB. Formerly, Dr. Dahl was Director at Moligo Technologies AB, Chief Technology Officer at Halo Genomics AB, and Chief Technology Officer at Vanadis Diagnostics AB. Education includes undergraduate and doctorate degrees from the University of Uppsala.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 07/05/2025 | 44,150 ( 0.27% ) | 444 692 $ | 31/05/2026 |
Fredrik Dahl active positions
| Companies | Position | Start |
|---|---|---|
| DEVYSER DIAGNOSTICS AB | Director/Board Member | 01/01/2021 |
Colibri Ventures AB | Founder | - |
Faboss Invest AB | Chairman | - |
Nucleus Capital AB | Director/Board Member | - |
Pixelgen Technologies AB
 Pixelgen Technologies AB Packaged SoftwareTechnology Services Develops bio-analytical tools for immune cell surface protein | Founder | - |
Llya Pharma AB | Director/Board Member | - |
Former positions of Fredrik Dahl
| Companies | Position | End |
|---|---|---|
Vanadis Diagnostics AB
 Vanadis Diagnostics AB Miscellaneous Commercial ServicesCommercial Services Develops novel solution for non-invasive prenatal testing | Chief Tech/Sci/R&D Officer | - |
Halo Genomics AB
 Halo Genomics AB Medical/Nursing ServicesHealth Services Develops products for preparation of DNA for the next generation sequencing platforms | Chief Tech/Sci/R&D Officer | - |
Moligo Technologies AB
 Moligo Technologies AB BiotechnologyHealth Technology Engages in producing ultrapure DNA | Director/Board Member | - |
Training of Fredrik Dahl
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
2
1st degree connections
10
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 10 |
|---|---|
University of Uppsala
 University of Uppsala Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Halo Genomics AB
Halo Genomics AB Medical/Nursing ServicesHealth Services Develops products for preparation of DNA for the next generation sequencing platforms | Health Services |
Devyser Diagnostics AB
 Devyser Diagnostics AB Medical SpecialtiesHealth Technology Manufactures and sells diagnostic kits | Health Technology |
Vanadis Diagnostics AB
Vanadis Diagnostics AB Miscellaneous Commercial ServicesCommercial Services Develops novel solution for non-invasive prenatal testing | Commercial Services |
Colibri Ventures AB | |
Faboss Invest AB | |
Moligo Technologies AB
Moligo Technologies AB BiotechnologyHealth Technology Engages in producing ultrapure DNA | Health Technology |
Pixelgen Technologies AB
Pixelgen Technologies AB Packaged SoftwareTechnology Services Develops bio-analytical tools for immune cell surface protein | Technology Services |
Nucleus Capital AB | |
Llya Pharma AB |
- Stock Market
- Insiders
- Fredrik Dahl
